Google+ Facebook Twitter Twitter

Long Covid – first evidence of inflammatory micro clots

New research indicates that an overload of various inflammatory molecules “trapped” inside insoluble microscopic blood clots could be the cause of some of the lingering symptoms of long COVID.

The finding was made by Professor Resia Pretorius from Stellenbosch University.

She said: “We found high levels of various inflammatory molecules trapped in micro clots present in the blood of individuals with long COVID. Some of the trapped molecules contain clotting proteins such as fibrinogen, as well as alpha(2)-antiplasmin.”

Alpha(2)-antiplasmin is a molecule that prevents the breakdown of blood clots, while fibrinogen is the main clotting protein. Under normal conditions the body’s plasmin–antiplasmin system maintains a fine balance between blood clotting and fibrinolysis.

With high levels of alpha(2)-antiplasmin in the blood of COVID-19 patients and those suffering from long COVID, the body’s ability to break down the clots is significantly inhibited.

Further research is recommended into a regimen of therapies to support clotting and fibrinolytic system function in individuals with lingering long COVID symptoms.

Image credit | Science-Photo-Library

Related Articles

Role of glucose in a deadly kidney disease

A research team has developed a new approach to better understand the biology of polycystic kidney disease (PKD).

Recent advances and updates in biomedical science

Deputy Editor Guy Orchard summarises a review paper and looks at planned special issues of the British Journal of Biomedical Science.

Replacing injections with pills?

A new paper explores a better way of delivering medications that does not require injections but could be as easy as swallowing a pill.

Trial to rapidly find flu treatments

A national trial has launched that aims to use pandemic lessons to help quickly find effective treatments for people hospitalised with severe flu.